340 related articles for article (PubMed ID: 24237427)
21. Extended-spectrum beta-lactam resistance due to AmpC hyperproduction and CMY-2 coupled with the loss of OMPK35 in Malaysian strains of Escherichia coli and Klebsiella pneumoniae.
Palasubramaniam S; Subramaniam G; Muniandy S; Parasakthi N
Microb Drug Resist; 2007; 13(3):186-90. PubMed ID: 17949305
[TBL] [Abstract][Full Text] [Related]
22. [Detection of plasmid-mediated AmpC beta-lactamase in clinical isolates of cefoxitin-resistant Escherichia coli and Klebsiella pneumoniae].
Coşkun S; Altanlar N
Mikrobiyol Bul; 2012 Jul; 46(3):375-85. PubMed ID: 22951650
[TBL] [Abstract][Full Text] [Related]
23. High prevalence of carbapenem resistance among plasmid-mediated AmpC β-lactamase-producing Klebsiella pneumoniae during outbreaks in liver transplantation units.
Matsumura Y; Tanaka M; Yamamoto M; Nagao M; Machida K; Ito Y; Takakura S; Ogawa K; Yoshizawa A; Fujimoto Y; Okamoto S; Uemoto S; Ichiyama S
Int J Antimicrob Agents; 2015 Jan; 45(1):33-40. PubMed ID: 25455850
[TBL] [Abstract][Full Text] [Related]
24. Dissemination of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli in Thai hospitals.
Niumsup PR; Tansawai U; Boonkerd N; Polwichai P; Dejsirilert S
J Infect Chemother; 2008 Dec; 14(6):404-8. PubMed ID: 19089552
[TBL] [Abstract][Full Text] [Related]
25. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein.
Bradford PA; Urban C; Mariano N; Projan SJ; Rahal JJ; Bush K
Antimicrob Agents Chemother; 1997 Mar; 41(3):563-9. PubMed ID: 9055993
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of screening methods to detect plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis.
Tan TY; Ng LS; He J; Koh TH; Hsu LY
Antimicrob Agents Chemother; 2009 Jan; 53(1):146-9. PubMed ID: 18955528
[TBL] [Abstract][Full Text] [Related]
27. Phenotypic Identification and Genotypic Characterization of Plasmid-Mediated AmpC β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae Isolates in Iran.
Robatjazi S; Nikkhahi F; Niazadeh M; Amin Marashi SM; Peymani A; Javadi A; Kashani AH
Curr Microbiol; 2021 Jun; 78(6):2317-2323. PubMed ID: 33837818
[TBL] [Abstract][Full Text] [Related]
28. An Increase in the clinical isolation of acquired AmpC β-lactamase-producing Klebsiella pneumoniae in Korea from 2007 to 2010.
Park MJ; Kim TK; Song W; Kim JS; Kim HS; Lee J
Ann Lab Med; 2013 Sep; 33(5):353-5. PubMed ID: 24003426
[TBL] [Abstract][Full Text] [Related]
29. Diversity of bla genes and low incidence of CTX-M in plasmid-mediated AmpC-producing Escherichia coli clinical isolates.
Galán-Sánchez F; Aznar-Marín P; Marín-Casanova P; Rodríguez-Iglesias M
APMIS; 2014 Sep; 122(9):796-9. PubMed ID: 24372614
[TBL] [Abstract][Full Text] [Related]
30. Molecular characteristics of extended spectrum beta-lactamases in Escherichia coli and Klebsiella pneumoniae and the prevalence of qnr in Extended spectrum beta-lactamase isolates in a tertiary care hospital in Korea.
Kim MH; Lee HJ; Park KS; Suh JT
Yonsei Med J; 2010 Sep; 51(5):768-74. PubMed ID: 20635454
[TBL] [Abstract][Full Text] [Related]
31. Prevalence and antimicrobial resistance patterns of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated from blood cultures in an Istanbul University Hospital.
Koksal F; Ak K; Kucukbasmaci O; Samasti M
Chemotherapy; 2009; 55(4):293-7. PubMed ID: 19521075
[TBL] [Abstract][Full Text] [Related]
32. Extended-spectrum beta-lactamases in ceftazidime-resistant Escherichia coli and Klebsiella pneumoniae isolates in Turkish hospitals.
Hoşoğlu S; Gündes S; Kolayli F; Karadenizli A; Demirdağ K; Günaydin M; Altindis M; Caylan R; Ucmak H
Indian J Med Microbiol; 2007 Oct; 25(4):346-50. PubMed ID: 18087082
[TBL] [Abstract][Full Text] [Related]
33. High prevalence of extended-spectrum beta-lactamases and plasmid-mediated AmpC beta-lactamases in Enterobacteriaceae isolated from long-term care facilities in Korea.
Yoo JS; Byeon J; Yang J; Yoo JI; Chung GT; Lee YS
Diagn Microbiol Infect Dis; 2010 Jul; 67(3):261-5. PubMed ID: 20462727
[TBL] [Abstract][Full Text] [Related]
34. Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae causing intra-abdominal infections from 9 tertiary hospitals in China.
Liao K; Chen Y; Wang M; Guo P; Yang Q; Ni Y; Yu Y; Hu B; Sun Z; Huang W; Wang Y; Wu A; Feng X; Luo Y; Hu Z; Chu Y; Chen S; Cao B; Su J; Gui B; Duan Q; Zhang S; Shao H; Kong H; Xu Y
Diagn Microbiol Infect Dis; 2017 Jan; 87(1):45-48. PubMed ID: 27773544
[TBL] [Abstract][Full Text] [Related]
35. High prevalence of multidrug resistant ESBL- and plasmid mediated AmpC-producing clinical isolates of Escherichia coli at Maputo Central Hospital, Mozambique.
Estaleva CEL; Zimba TF; Sekyere JO; Govinden U; Chenia HY; Simonsen GS; Haldorsen B; Essack SY; Sundsfjord A
BMC Infect Dis; 2021 Jan; 21(1):16. PubMed ID: 33407206
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of plasmid-mediated AmpC beta-lactamases in Escherichia coli and Klebsiella pneumoniae in Korea.
Lee K; Lee M; Shin JH; Lee MH; Kang SH; Park AJ; Yong D; Chong Y
Microb Drug Resist; 2006; 12(1):44-9. PubMed ID: 16584308
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of acquired fosfomycin resistance among extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Korea and IS26-composite transposon surrounding fosA3.
Lee SY; Park YJ; Yu JK; Jung S; Kim Y; Jeong SH; Arakawa Y
J Antimicrob Chemother; 2012 Dec; 67(12):2843-7. PubMed ID: 22893681
[TBL] [Abstract][Full Text] [Related]
38. [Typing of extended-spectrum beta-lactamases in Escherichia coli and Klebsiella spp. strains and analysis of plasmid profiles].
Oksüz L; Gürler N
Mikrobiyol Bul; 2009 Apr; 43(2):183-94. PubMed ID: 19621602
[TBL] [Abstract][Full Text] [Related]
39. Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae.
Papanicolaou GA; Medeiros AA; Jacoby GA
Antimicrob Agents Chemother; 1990 Nov; 34(11):2200-9. PubMed ID: 1963529
[TBL] [Abstract][Full Text] [Related]
40. [Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
Kuzucu C; Yetkin F; Görgeç S; Ersoy Y
Mikrobiyol Bul; 2011 Jan; 45(1):28-35. PubMed ID: 21341156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
